Although Edwards Lifesciences (NYSE: EW) performed more or less in line with analyst expectations in its most recently completed quarter, the company's guidance left something to be desired. Unfortunately for the medical device maker, its third-quarter earnings release dropped on a very bearish day for the market.

As a result, unforgiving investors punished it by knocking its stock price down by over 8%.

Edwards posted its third-quarter earnings after market close on Wednesday, receiving investor blowback the following day.

Continue reading

Source Fool.com